Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
Abstract The use of chimeric antigen receptor (CAR)-T cells has enhanced the range of available therapeutic modalities in the context of cancer treatment. CAR-T cells have demonstrated considerable efficacy in the targeted eradication of blood cancer cells, thereby stimulating substantial interest i...
Saved in:
Main Authors: | Marat Khaliulin, Aygul Valiullina, Alexey Petukhov, Youyong Yuan, Sheila Spada, Emil Bulatov |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03817-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01) -
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
by: Zhao Zhang, et al.
Published: (2025-01-01) -
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
by: Xin-Yu Zhu, et al.
Published: (2025-01-01) -
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
by: P. Joy Ho, et al.
Published: (2025-01-01) -
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
by: Fatemeh Dehghan, et al.
Published: (2025-02-01)